Collegium Pharmaceutical (NASDAQ:COLL) reported its Q3 earnings results on Tuesday, November 7, 2023 at 04:01 PM.
Here’s what investors need to know about the announcement.
Earnings
Collegium Pharmaceutical beat estimated earnings by 157.69%, reporting an EPS of $1.34 versus an estimate of $0.52.
Revenue was up $9.70 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.04 which was followed by a 6.68% increase in the share price the next day.
Here’s a look at Collegium Pharmaceutical’s past performance:
| Quarter | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|
| EPS Estimate | 1.22 | 0.31 | -0.14 | -0.13 |
| EPS Actual | 1.26 | 1.32 | 1.09 | 1.10 |
| Revenue Estimate | 137.98M | 138.47M | 125.19M | 124.45M |
| Revenue Actual | 135.55M | 144.77M | 129.62M | 127.01M |
To track all earnings releases for Collegium Pharmaceutical visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
